Skip to Content

Our flagship
7-day patch technology
Corplex®  

Corplex® 7-day patch technology

MATRIX PATCH TECHNOLOGY

Corplex® is the subject of several US and international patents. These fundamentally cover a broad range of adhesive systems and bioavailability enhancement approaches for small molecules. 

FDA-approved 7-day continuous delivery patch

Our FDA-approved 7-day continuous delivery patch containing the widely prescribed drug Donepezil for the treatment of Alzheimer’s Disease, was developed via the Corplex® platform. 

The innovation driver for this product is the in-patch conversion process to transform the salt form of drug to a higher bioavailability, free-base form of donepezil that results in higher levels of drug being absorbed across the skin. In addition, the transdermal delivery of donepezil potentially results in fewer GI-related adverse events relative to oral delivery of the drug. 

Key features
CORPLEX® TECHNOLOGY

  • Range of adhesive properties for aqueous and lipid delivery
  • Improved drug bioavailability and high drug loading
  • Excellent adhesion to both wet and dry surfaces
  • Flexibility with natural skin movement
  • Continuous delivery to 7 days from a single patch
  • Patent protection
Corplex® Patch Technology
DOWNLOAD OUR CORPLEX® TECHNOLOGY BROCHURE

PARTNERING WITH US
FOR SUCCESS

We can provide assistance in the following areas depending upon your marketing needs:

  • Innovative, patented products for specialty pharmaceutical companies
  • Life Cycle Management expertise for new chemical entities
  • Bioequivalent products for the lower-cost, generic market
  • Unique OTC consumer products that provide market differentiation

Please reach out to our business development
team for further information:

Kevin Ostrander, Corium Innovations
Kevin Ostrander MS, MBA
Dwayne Sharper, Corium Innovations
Dwayne Sharpe